FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

28,933 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 600 - 800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
implementation.guide.nhdrR4IndigenousGroupValueSetIndigenousGroupValueSetdraftexample
implementation.guide.nhdrR4MaritalStatusValueSetMaritalStatusValueSetdraftexample
implementation.guide.nhdrR4OrganizationTypeValueSetOrganizationTypeValueSetdraftexample
implementation.guide.nhdrR4PractitionerRoleValueSetPractitionerRoleValueSetdraftexample
implementation.guide.nhdrR4SexValueSetSexValueSetdraftexample
d4l-data4life.covid-19.r4R4pregnancy-de.ValueSetPregnant|Not pregnant|Unknownactiveloinc
de.abda.erezeptabgabedatenpkvR4DAV-PKV-VS-ERP-AbrechnungsTypDAV_PKV_VS_ERP_AbrechnungsTypactive
de.abda.erezeptabgabedatenpkvR4DAV-PKV-VS-ERP-ZusatzattributSchluesselAutidemAustauschDAV_PKV_VS_ERP_ZusatzattributSchluesselAutidemAustauschactive
de.abda.erezeptabgabedatenpkvR4DAV-PKV-VS-ERP-ZusatzdatenEinheitFaktorkennzeichenDAV_PKV_VS_ERP_ZusatzdatenEinheitFaktorkennzeichenactive
de.thieme-compliance.anamneseR4UiWidgetsVSUiWidgetsdraft2023-05
de.bbmri.fhirR4BiobankCapabilitiesBiobank Capabilitiesactive2020-05
de.bbmri.fhirR4CollectionTypeCollection Typeactive2020-05
de.bbmri.fhirR4DataCategoryData Categoryactive2020-05
de.bbmri.fhirR4OtherSampleDiagnosisother sample diagnosisactive2020-05
de.bbmri.fhirR4QualityStandardQuality Standardactive2020-05
de.bbmri.fhirR4ResourceTypeResource Typeactive2020-05
de.bbmri.fhirR4SampleMaterialTypeSample Material Typeactive2020-05
de.bbmri.fhirR4StorageTemperatureStorage Temperatureactive2020-05
us.nlm.vsacR41.2.91.13925.17760.1280649Sneezing and Itching Groupingactive2017-06usvsac
us.nlm.vsacR41.2.91.13925.17760.15972546Conditions Indicating Appropriate Sinonasal Imagingactive2017-06usvsac
us.nlm.vsacR41.2.91.13925.17760.16432390Cerumen Impactionactive2017-06usvsac
us.nlm.vsacR41.2.91.13925.17760.16929355Allergic Rhinitis Groupingactive2017-06usvsac
us.nlm.vsacR41.2.91.13925.17760.18316962Severe Asthmaactive2017-06usvsac
us.nlm.vsacR41.2.91.13925.17760.19613338Immunoglobulin G Testing Groupingactive2022-03usvsac
us.nlm.vsacR41.2.91.13925.17760.23618223Hearing Aids Groupingactive2017-06usvsac
us.nlm.vsacR41.2.91.13925.17760.24927846Specific IgE testingactive2017-06uscpt
us.nlm.vsacR41.2.91.13925.17760.26050446Ear Surgery Affecting the Tympanic Membraneactive2017-06uscpt
us.nlm.vsacR41.2.91.13925.17760.26878039Specific IgE Testingactive2022-03usvsac
us.nlm.vsacR41.2.91.13925.17760.29996863Immunoglobulin G testingactive2017-06uscpt
us.nlm.vsacR41.2.91.13925.17760.4352590Benign Prostatic Hyperplasiaactive2017-08usvsac
us.nlm.vsacR41.2.91.8867.26816.649902Office or Outpatient Encounteractive2017-07uscpt
us.nlm.vsacR41.3.6.1.4.1.33895.1.3.0.45Comfort Measuresactive2021-02ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1pain medication action planactive2015-08ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.3.2All prescribable opioids used for pain control including Inactive Medicationsactive2015-08ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.1malignant neoplasms and cancer painactive2015-08ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.2malignant neoplasms and cancer painactive2015-08ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.7malignant neoplasms and cancer painactive2015-08ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.9malignancy or cancer related painactive2015-08ushl7vsac
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150Cerumen on Otoscopyactive2017-02ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151Cerumen on Otoscopyactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152Cerumen on Otoscopyactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172Hearing Lossactive2017-02ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173Hearing Lossactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174Hearing Lossactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175Tinnitusactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176Tinnitusactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177Tinnitusactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178Ear Congestionactive2017-02ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179Ear Pruritusactive2017-02ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180Otalgiaactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181Otalgiaactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182Otalgiaactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96Initial Encounter with Otolaryngologist or undefined clinicianactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204Hearing Aidsactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205Hearing Aidsactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206Hearing Aidsactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81Cerumen Impactionactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82Cerumen Impactionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190Radiotherapyactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191Head and Neck Anatomic Locationsactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192Conditions Associated with Head and Neck Radiotherapyactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194Ear Canal Stenosisactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195Ear Canal Stenosisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196Ear Canal Stenosisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197Exostosesactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198Exostosesactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199Exostosesactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200Non intact Tympanic Membraneactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201Non Intact Tympanic Membraneactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202Non Intact Tympanic Membraneactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246Hearing Aidsactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250DO NOT USEactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251Cerumenolyticsactive2017-03ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252Irrigationactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253Irrigationactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288Otoscopy performed on examactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291Otolaryngologist as a Clinician or Serviceactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123Cerumen Impactionactive2017-02ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275Dermatologic Diseases of the Earactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20Keratoses Obturansactive2017-02ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221Tympanoplastyactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222Tympanoplastyactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223Myringoplastyactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224Myringoplastyactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225Mastoidectomyactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229Mastoidectomyactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227Ear Surgery, Otheractive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228Ear Surgery, Otheractive2018-01ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334Sleep Apneaactive2018-05ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336Sleep Apneaactive2018-05ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237Allergic Rhinitisactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238Allergic Rhinitisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239Allergic Rhinitisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263Uncontrolled or severe asthmaactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264Uncontrolled or severe asthmaactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265Uncontrolled or severe asthmaactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300Rhinosinusitisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301Rhinosinusitisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302Rhinosinusitisactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303Nasal Polyposisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304Nasal Polyposisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305Nasal Polyposisactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306Suspected Nasal Neoplasmactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307Suspected Nasal Neoplasmactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308Suspected Nasal Neoplasmactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309Other sinus conditions potentially requiring imagingactive2017-08ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310Other sinus conditions potentially requiring imagingactive2017-08ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319Intranasal Antihistaminesactive2017-06ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320Mast Cell Stabilizersactive2017-06ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321Ophthalmic Antihistaminesactive2017-06ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215Sneezing as a findingactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216Sneezing as a Clinical Conditionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217Pruritus Unspecified or Other Locationactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218Pruritus Unspecified or Other Locationactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272Specific IgE Testing for Allergiesactive2017-03ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273Immunoglobulin G Testingactive2017-03ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274Total IgE Testingactive2017-03ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290Clinicians who perform allergy testingactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279Radiography of face, head or neckactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315Intranasal Corticosteroidsactive2017-03ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316Eustachian Tube Dysfunctionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317Eustachian Tube Dysfunctionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318Eustachian Tube Dysfunctionactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287Oral Second Generation and Less Sedating Antihistaminesactive2017-05ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266Leukotriene antagonistactive2017-03ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267Immunotherapy that is not Identified as Subcutaneousactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268Immunotherapyactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653Fidaxomicinactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657Clostridium difficile infectionactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594Complete Blood Count (with Diff)active2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662Metronidazole Systemicactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663Vancomycin non injectableactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665Creatinineactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722Ileus due to infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723Ileus due to infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724Ileus due to infectionactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725Vomiting potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726Vomiting potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727Vomiting potentially due to CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728Toxic Megacolon in adultsactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729Toxic Megacolon in adultsactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730Toxic Megacolon in adultsactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731Abdominal Distensionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732Abdominal Distensionactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688Septic Shock due to C. Diffactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689Septic Shock due to C. Diffactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690Septic Shock due to C. Diffactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658Antiperistaltic agents to avoid in C. diffactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734Systemic Antimicrobial Medications not used for CDIactive2019-05ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659Recurrent Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660History of CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661Consult Infectious Diseaseactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691Abdominal Xrays for CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692CT of abdomen with contrast for fulminant CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693Surgical consult for CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694Fecal microbiota transplantationactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645Hospitalistactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697Positive result indicatoractive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698Clostridium Difficile Testactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646Body Temperatureactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647Body Temperatureactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648Diarrhea Potentially due to CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649Diarrhea Potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650Diarrhea Potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651Leukocyte countactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652Inpatient Settingactive2019-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1010.4Medication Clinical Drugactive2024-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1010.5Medication Clinical Brand specific Drugactive2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1010.6CVX Vaccines Administered Vaccine Setactive2025-04ushl7cvx
us.nlm.vsacR42.16.840.1.113762.1.4.1021.102Unknown or did not answeractive2021-10ushl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.103Other or unknown or refused to answeractive2021-11ushl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.12Low Molecular Weight Heparin for VTE prophylaxis ingredient specificactive2025-04ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1021.14Published test VSactive2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1021.24Birth Sexactive2024-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1021.46Device Magnetic resonance (MR) Safetyactive2024-06ushl7ncit
us.nlm.vsacR42.16.840.1.113762.1.4.1021.47Device Latex Safetyactive2024-06ushl7ncit
us.nlm.vsacR42.16.840.1.113762.1.4.1021.48Implantable Device Statusactive2024-06ushl7ncit
us.nlm.vsacR42.16.840.1.113762.1.4.1021.56Medical Reason Not Done SCTactive2019-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.119Phototherapyactive2021-06ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.120Phototherapyactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.121Phototherapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.122Neonatal Jaundiceactive2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.123Neonatal Jaundiceactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.124Neonatal Jaundiceactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.125Maternal Drug Useactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.126Maternal Drug Useactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.127Maternal Drug Useactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.128Fetal Conditionsactive2025-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.129Fetal Conditionsactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.130Fetal Conditionsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.131Congenital Malformationsactive2025-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.132Congenital Malformationsactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.133Congenital Malformationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.134Social Indicationsactive2024-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.135Social Indicationsactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.136Social Indicationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.137Neonatal Severe Birth Traumaactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.138Neonatal Severe Birth Traumaactive2025-05ushl7sct